US20160256089A1 - Pulse photometer and method for calculating concentration of light absorber in blood - Google Patents

Pulse photometer and method for calculating concentration of light absorber in blood Download PDF

Info

Publication number
US20160256089A1
US20160256089A1 US15/059,564 US201615059564A US2016256089A1 US 20160256089 A1 US20160256089 A1 US 20160256089A1 US 201615059564 A US201615059564 A US 201615059564A US 2016256089 A1 US2016256089 A1 US 2016256089A1
Authority
US
United States
Prior art keywords
variation
light
light beam
blood
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US15/059,564
Other versions
US10524704B2 (en
Inventor
Yoshinori Ueda
Teiji Ukawa
Kazumasa Ito
Hideki Fujisaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Kohden Corp
Original Assignee
Nihon Kohden Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2016008856A external-priority patent/JP6703841B2/en
Application filed by Nihon Kohden Corp filed Critical Nihon Kohden Corp
Assigned to NIHON KOHDEN CORPORATION reassignment NIHON KOHDEN CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FUJISAKI, HIDEKI, ITO, KAZUMASA, UEDA, YOSHINORI, UKAWA, TEIJI
Publication of US20160256089A1 publication Critical patent/US20160256089A1/en
Application granted granted Critical
Publication of US10524704B2 publication Critical patent/US10524704B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes

Definitions

  • the presently disclosed subject matter relates to a pulse photometer for calculating the concentration of a light absorption material in blood of a subject (hereinafter, the concentration is often referred to as “blood light absorber concentration”), and a method for calculating the blood light absorber concentration by using the pulse photometer.
  • a pulse photometer is an apparatus which measures the blood light absorber concentration of the subject. Specifically, the living tissue of the subject is irradiated with light beams at a plurality of wavelengths which have different ratios of the blood light absorbances depending on the blood light absorber concentration. The intensities of the light beams at the wavelengths transmitted through or reflected from the living tissue are detected. The intensities at the wavelengths are changed in accordance with the pulsation of the blood in the subject. Therefore, temporal changes of the intensities at the wavelengths due to the pulsation are acquired in the form of a pulse wave signal. The amplitudes of pulse wave signals with respect to waveforms correspond to light attenuation variations with respect to the waveforms, respectively. The blood light absorber concentration calculated based on a ratio of light attenuation variations with respect to waveforms (for example, see Japanese Patent No. 4,196,209).
  • the blood light absorber concentration As an example of the blood light absorber concentration, known is the arterial oxygen saturation (hereinafter, referred to as the SaO2) which is used as an index of oxygenation of blood.
  • the SaO2 the arterial oxygen saturation
  • an invasive measurement must be performed. Therefore, the transcutaneous arterial oxygen saturation (hereinafter, referred to as the SpO2) which can be non-invasively calculated is widely used as the index.
  • the SpO2 is measured by a pulse oximeter which is an example of a pulse photometer.
  • the value of the calculated SpO2 is equal to that of the actual SaO2.
  • the values are different from each other under certain conditions.
  • the value of the SpO2 tends to be calculated to be higher than that of the actual SaO2.
  • a situation where, even when the value of the SpO2 indicates the normal condition of the subject, the subject actually suffers hypoxemia is possibly caused.
  • the presently disclosed subject matter may provide an apparatus and a method to improve the accuracy of a blood light absorber concentration which is non-invasively calculated.
  • a pulse photometer comprising: a first variation acquirer which is configured to acquire a first variation corresponding to a light attenuation variation of a first light beam due to pulsation of blood in a subject, based on a first intensity signal corresponding to an intensity of the first light beam that is transmitted through or reflected from a body of the subject, and that has a first wavelength; a second variation acquirer which is configured to acquire a second variation corresponding to a light attenuation variation of a second light beam due to the pulsation of the blood in the subject, based on a second intensity signal corresponding to an intensity of the second light beam that is transmitted through or reflected from the body of the subject, and that has a second wavelength; and a concentration calculator which is configured to calculate a blood light absorber concentration, based on the first variation and the second variation, the second variation containing a first offset which is based on an inverse of the light attenuation variation of the first light beam.
  • FIG. 1 is a block diagram illustrating the functional configuration of a pulse oximeter of a first embodiment.
  • FIGS. 2(A) and 2(B) are views illustrating the operation of the pulse oximeter of FIG. 1 .
  • FIG. 3 is a block diagram illustrating the functional configuration of a pulse oximeter of a second embodiment.
  • FIGS. 4(A) and 4(B) are views illustrating the operation of the pulse oximeter of FIG. 3 .
  • FIG. 1 is a block diagram illustrating the functional configuration of a pulse oximeter 1 (an example of the pulse photometer) of a first embodiment.
  • the pulse oximeter 1 is an apparatus which measures the SpO2 of a subject 2 .
  • the SpO2 indicates a ratio (an example of the blood light absorber concentration) of oxyhemoglobin (an example of the blood light absorber) to the amount of hemoglobin capable of carrying oxygen.
  • the pulse oximeter 1 can include a first light emitter 11 .
  • the first light emitter 11 is configured so as to emit a first light beam having a first wavelength ⁇ 1 .
  • Examples of the first wavelength ⁇ 1 are 880 nm and 940 nm (examples of the infrared light beam).
  • the first light emitter 11 is a semiconductor light emitting device which can emit the first light beam. Examples of the semiconductor light emitting device are a light emitting diode (LED), a laser diode, and an organic electroluminescence.
  • the pulse oximeter 1 can include a second light emitter 12 .
  • the second light emitter 12 is configured so as to emit a second light beam having a second wavelength ⁇ 2 .
  • Examples of the second wavelength ⁇ 2 are 630 nm and 660 nm (examples of the red light beam).
  • the second light emitter 12 is a semiconductor light emitting device which can emit the second light beam. Examples of the semiconductor light emitting device are a light emitting diode (LED), a laser diode, and an organic electroluminescence.
  • the pulse oximeter 1 can include a light detector 20 .
  • the light detector 20 is configured so as to output a first intensity signal I 1 in accordance with the intensity of the first light beam transmitted through or reflected from the body of the subject 2 .
  • the light detector 20 is configured so as to output a second intensity signal I 2 in accordance with the intensity of the second light beam transmitted through or reflected from the body of the subject 2 .
  • the light detector 20 is an optical sensor having a sensitivity to, for example, the first wavelength ⁇ 1 and the second wavelength ⁇ 2 . Examples of the optical sensor are a photodiode, a phototransistor, and a photoresistor.
  • the pulse oximeter 1 can include a first variation acquirer 31 .
  • the first variation acquirer 31 is configured so as to acquire a light attenuation variation ⁇ A 1 of the first light beam due to the blood pulsation of the subject 2 based on a temporal change of the first intensity signal I 1 output from the light detector 20 .
  • the light attenuation variation ⁇ A 1 of the first light beam is expressed by the following expression:
  • ⁇ I 1 indicates the variation of the first intensity signal I 1 due to the blood pulsation of the subject 2 .
  • the pulse oximeter 1 can include a second variation acquirer 32 .
  • the second variation acquirer 32 is configured so as to acquire a light attenuation variation ⁇ A 2 of the second light beam due to the blood pulsation of the subject 2 based on a temporal change of the second intensity signal I 2 output from the light detector 20 .
  • the light attenuation variation ⁇ A 2 of the second light beam is expressed by the following expression:
  • ⁇ I 2 indicates the variation of the second intensity signal I 2 due to the blood pulsation of the subject 2 .
  • the value of the SpO2 acquired by the pulse oximeter tends to be higher than that of the arterial oxygen saturation (hereinafter, referred to as the SaO2) which is invasively acquired.
  • the inventors have focused on the light attenuation variation ⁇ A 1 of the first light beam corresponding to the amplitude of the pulse wave signal, and investigated a relationship between the variation and the difference between the value of the SpO2 and that of the SaO2.
  • FIG. 2(A) illustrates results of the investigation.
  • the abscissa represents the inverse of the light attenuation variation ⁇ A 1 of the first light beam. Therefore, the figure illustrates a situation where the larger the value, the lower the amplitude of the pulse wave signal.
  • the ordinate represents the difference between the value of the SpO2 and that of the SaO2. Namely, the ordinate indicates the bias contained in the value of the acquired SpO2.
  • the inventors have found that the inverse of the light attenuation variation ⁇ A 1 of the first light beam and the bias contained in the value of the acquired SpO2 are in proportional relationships. That is, the following expression is obtained:
  • the value of the SaO2 can be regarded as a reference value for the SpO2 acquired by the pulse oximeter. From Expression (3), the reference value can be expressed by the following expression:
  • Expression (3) can be regarded as an offset necessary for obtaining the accurate value of the SpO2.
  • Expression (4) it is seen that the reference value is obtained by adding the offset to the value of the SpO2 acquired by the pulse oximeter.
  • the value of the SpO2 acquired by the pulse oximeter can approach that of the SaO2 by adding an offset corresponding to the proportional constant k 1 which is obtained from the relationships shown in FIG. 2(A) , to the light attenuation variation ⁇ A 2 of the second light beam.
  • the first variation acquirer 31 is configured so as to acquire a first variation ⁇ 1 corresponding to the light attenuation variation ⁇ A 1 of the first light beam.
  • the first variation ⁇ 1 is substantially identical to the light attenuation variation ⁇ A 1 of the first light beam.
  • the second variation acquirer 32 is configured so as to acquire a second variation ⁇ 2 corresponding to the light attenuation variation ⁇ A 2 of the second light beam.
  • the second variation ⁇ 2 is set as the following expression based on the above-described finding:
  • k 1 is regarded as the first offset based on the inverse of the light attenuation variation ⁇ A 1 of the first light beam. That is, the second variation ⁇ 2 contains the first offset k 1 .
  • the pulse oximeter 1 can include a concentration calculator 40 .
  • the concentration calculator 40 is configured so as to calculate the SpO2 of the subject 2 based on the first variation ⁇ 1 acquired by the first variation acquirer 31 , and the second variation ⁇ 2 acquired by the second variation acquirer 32 .
  • the concentration calculator is configured so as to calculate the SpO2 based on Expression (5).
  • FIG. 2(B) illustrates the difference between the value of the SpO2 which is calculated by the pulse oximeter 1 including the concentration calculator 40 , and that of the SaO2. It is seen that, although the difference between the values is not eliminated, the bias in a region where the pulse wave amplitude is low (region where the inverse of the light attenuation variation ⁇ A 1 of the first light beam is large) is reduced as compared with the example in which the first offset k 1 is not used. According to the configuration, therefore, it is possible to improve the accuracy of the SpO2 which is non-invasively calculated.
  • the value of the first offset k 1 may be adequately determined.
  • the value of the first offset k 1 is previously statistically determined based on a plurality of difference values between the SpO2 and the SaO2 which are acquired from a plurality of subjects. Specifically, a statistical process such as the least squares method is applied to a plurality of measurement results such as shown in FIG. 2(A) , and the first offset k 1 by which the difference between the SpO2 and the SaO2 can be reduced is determined.
  • the second variation acquirer 32 operates based on the first offset k 1 which is a constant that is statistically determined. Therefore, the reliability of the first offset k 1 can be improved, and furthermore the processing load of the second variation acquirer 32 can be reduced. Consequently, the accuracy of the SpO2 which is non-invasively calculated can be easily improved.
  • an infrared light beam is used as the first light beam
  • a red light beam is used as the second light beam.
  • a red light beam may be used as the first light beam
  • an infrared light beam may be used as the second light beam.
  • the embodiment is configured so that the common light detector 20 detects the first light beam emitted from the first light emitter 11 , and the second light beam emitted from the second light emitter 12 .
  • a configuration may be employed where a light detector for detecting the first light beam, and that for detecting the second light beam are arranged independently from each other.
  • FIG. 3 is a diagram illustrating the functional configuration of a pulse oximeter 1 A of a second embodiment. Portions which are identical or substantially identical with those of the pulse oximeter 1 of the first embodiment are denoted by the same reference numerals, and duplicated descriptions are omitted.
  • the pulse oximeter 1 A can include a third light emitter 13 .
  • the third light emitter 13 is configured so as to emit a third light beam having a third wavelength ⁇ 3 .
  • Examples of the third wavelength ⁇ 3 are 700 nm (an example of the red light beam) 730 nm (an example of the red light beam), and 805 nm (an example of the infrared light beam).
  • the third light emitter 13 is a semiconductor light emitting device which can emit the third light beam. Examples of the semiconductor light emitting device are a light emitting diode (LED), a laser diode, and an organic electroluminescence.
  • the light detector 20 is configured so as to output a third intensity signal I 3 in accordance with the intensity of the third light beam transmitted through or reflected from the body of the subject 2 .
  • the pulse oximeter 1 A can include a third variation acquirer 33 .
  • the third variation acquirer 33 is configured so as to acquire a light attenuation variation ⁇ A 3 of the third light beam due to the blood pulsation of the subject 2 based on a temporal change of the third intensity signal I 3 output from the light detector 20 .
  • the light attenuation variation ⁇ A 3 of the third light beam is expressed by the following expression:
  • ⁇ I 3 indicates the variation of the third intensity signal I 3 due to the blood pulsation of the subject 2 .
  • FIG. 4(A) illustrates relationships of the inverse of the light attenuation variation ⁇ A 1 of the first light beam in the case where the SpO2 is measured by using the three wavelengths, and the difference between the value of the SpO2 and that of the SaO2.
  • the abscissa corresponds to the former, and the ordinate corresponds to the latter.
  • the inventors have found that, also in the case where the three wavelengths are used, the inverse of the light attenuation variation ⁇ A 1 of the first light beam and the bias contained in the value of the acquired SpO2 are in proportional relationships.
  • the value of the SpO2 acquired by the pulse oximeter can approach that of the SaO2 by adding the first offset k 1 which is obtained from the relationships shown in FIG. 4(A) , to the light attenuation variation ⁇ A 2 of the second light beam, and further adding a second offset k 2 to the light attenuation variation ⁇ A 3 of the third light beam.
  • the third variation acquirer 33 is configured so as to acquire a third variation ⁇ 3 corresponding to the light attenuation variation ⁇ A 3 of the third light beam.
  • the third variation ⁇ 3 is set as the following expression based on the above-described finding:
  • k 2 is regarded as the second offset based on the inverse of the light attenuation variation ⁇ A 1 of the first light beam. That is, the third variation ⁇ 3 contains the second offset k 2 .
  • the pulse oximeter 1 A can include a concentration calculator 40 A.
  • the concentration calculator 40 A is configured so as to calculate the SpO2 of the subject 2 based on the first variation ⁇ 1 acquired by the first variation acquirer 31 , the second variation ⁇ 2 acquired by the second variation acquirer 32 , and the third variation ⁇ 3 acquired by the third variation acquirer 33 .
  • the concentration calculator is configured so as to perform the process described below.
  • the light attenuation variations ⁇ A 1 , ⁇ A 2 , and ⁇ A 3 of the first, second, and third light beams are expressed by the following expressions:
  • E is the extinction coefficient (dl g ⁇ 1 cm ⁇ 1 )
  • Hb is the hemoglobin concentration of blood (g dl ⁇ 1 )
  • indicates the light attenuation rate (cm ⁇ 1 )
  • ⁇ D indicates the thickness change (cm) due to the blood pulsation.
  • the suffix “b” means blood
  • the suffix “t” means the tissue except blood
  • the suffix “1” means the first light beam
  • the suffix “2” means the second light beam
  • the suffix “3” means the third light beam.
  • Ex indicates a variable which is replaced with [( ⁇ t ⁇ Dt)/(Hb ⁇ Db)], the suffix “1” means the first light beam, the suffix “2” means the second light beam, and the suffix “3” means the third light beam.
  • the blood extinction coefficient Eb 2 of the second light beam, and the blood extinction coefficient Eb 3 of the third light beam can be approximated by the blood extinction coefficient Eb 1 of the first light beam in the following manner:
  • the suffix “1” means the first light beam
  • the suffix “2” means the second light beam
  • the suffix “3” means the third light beam
  • Ex 2 of the second light beam and Ex 3 of the third light beam can be approximated to by Ex 1 of the first light beam in the following manner:
  • the suffix “1” means the first light beam
  • the suffix “2” means the second light beam
  • the suffix “3” means the third light beam
  • the blood extinction coefficient Eb 1 is expressed by the following expression:
  • Eo is the extinction coefficient of oxyhemoglobin
  • Er is the extinction coefficient of deoxyhemoglobin
  • suffix “1” means the first light beam
  • the value of SpO2 acquired by the pulse oximeter can approach that of the SaO2 by adding the first offset k 1 to the light attenuation variation ⁇ A 2 of the second light beam, and adding the second offset k 2 to the light attenuation variation ⁇ A 3 of the third light beam.
  • the concentration calculator 40 A is configured so as to calculate the SpO2 based on the first variation ⁇ 1 acquired by the first variation acquirer 31 , the second variation ⁇ 2 acquired by the second variation acquirer 32 , and the third variation ⁇ 3 acquired by the third variation acquirer 33 .
  • FIG. 4(B) illustrates the difference between the value of the SpO2 which is calculated by the pulse oximeter 1 A including the concentration calculator 40 A, and that of the SaO2. It is seen that the bias in a region where the pulse wave amplitude is low (region where the inverse of the light attenuation variation ⁇ A 1 of the first light beam is large) is greatly reduced as compared with the example in which the first offset k 1 and the second offset k 2 are not used.
  • the values of the first offset k 1 and the second offset k 2 may be adequately determined.
  • the values of the first offset k 1 and the second offset k 2 are previously statistically determined based on a plurality of difference values between the SpO2 and the SaO2 which are acquired from a plurality of subjects. Specifically, a statistical process such as the least squares method is applied to a plurality of measurement results such as shown in FIG. 4(A) , and the first offset k 1 and second offset k 2 by which the difference between the SpO2 and the SaO2 can be reduced are determined.
  • the second variation acquirer 32 operates based on the first offset k 1 which is a constant that is statistically determined
  • the third variation acquirer 33 operates based on the second offset k 2 which is a constant that is statistically determined. Therefore, the reliabilities of the first offset k 1 and the second offset k 2 can be improved, and furthermore the processing loads of the second variation acquirer 32 and the third variation acquirer 33 can be reduced. Consequently, the accuracy of the SpO2 which is non-invasively calculated can be easily and remarkably improved.
  • an infrared light beam is used as the first light beam
  • a red light beam is used as the second and third light beams.
  • a red light beam may be used as the first light beam
  • a red light beam may be used as one of the second and third light beams
  • an infrared light beam may be used as the other one of the second and third light beams.
  • an infrared light beam may be used as two of the first, second, and third light beams
  • a red light beam may be used as the remaining one of the light beams.
  • the embodiment is configured so that the common light detector 20 detects the first light beam emitted from the first light emitter 11 , the second light beam emitted from the second light emitter 12 , and the third light beam emitted from the third light emitter 13 .
  • a configuration may be employed where at least one of the light detector for detecting the first light beam, that for detecting the second light beam, and that for detecting the third light beam is independently arranged.
  • the red light beam and the infrared light beam are a combination in which ratios of the blood light absorbances are varied depending on the oxygen saturation, and therefore particularly the accuracy of the calculation of the SpO2 can be improved.
  • a pulse oximeter for calculating the SpO2 has been exemplified.
  • the presently disclosed subject matter can be applied also to other kinds of pulse photometers which measure the concentration of another blood light absorber.
  • another blood light abosrober are carboxyhemoglobin, methhemoglobin, and a dye injected into blood vessels.
  • the wavelengths of the light beams are selected so that combinations can be produced in which ratios of the blood light absorbances are substantially different from each other depending on the target blood light absorber concentration.
  • a configuration may be employed where four or more light beams at four or more wavelengths are used for identifying the blood light absorber concentration.
  • four wavelengths ⁇ 1 , ⁇ 2 , ⁇ 3 , and ⁇ 4 may be selected as follows:
  • ⁇ 1 630 nm
  • ⁇ 2 660 nm
  • ⁇ 3 700 nm
  • ⁇ 4 880 nm
  • ⁇ 1 660 nm
  • ⁇ 2 700 nm
  • ⁇ 3 880 nm
  • ⁇ 4 940 nm.
  • the functions of the first variation acquirer 31 , the second variation acquirer 32 , the third variation acquirer 33 , and the concentration calculator 40 ( 40 A) are realized from software executed by a cooperation of a processor and memory which are communicable connected to each other.
  • the processor are a CPU and an MPU.
  • the memory are a RAM and a ROM.
  • at least one of the functions of the first variation acquirer 31 , the second variation acquirer 32 , the third variation acquirer 33 , and the concentration calculator 40 ( 40 A) may be realized by hardware such as circuit devices, or a combination of hardware and software.

Abstract

A pulse photometer includes: a first variation acquirer acquiring a first variation corresponding to a light attenuation variation of a first light beam due to pulsation of blood in a subject, based on a first intensity signal corresponding to an intensity of the first light beam that is transmitted through or reflected from a body of the subject, and that has a first wavelength; a second variation acquirer acquiring a second variation; and a concentration calculator calculating a blood light absorber concentration, based on the first and second variations, the second variation containing a first offset which is based on an inverse of the light attenuation variation of the first light beam.

Description

    CROSS-REFERENCE TO RELATED APPLICATION(S)
  • This application is based upon and claims the benefit of priority from prior Japanese patent applications No. 2015-042600, filed on Mar. 4, 2015, and No. 2016-008856, filed on Jan. 20, 2016, the entire contents of which are incorporated herein by reference.
  • BACKGROUND
  • The presently disclosed subject matter relates to a pulse photometer for calculating the concentration of a light absorption material in blood of a subject (hereinafter, the concentration is often referred to as “blood light absorber concentration”), and a method for calculating the blood light absorber concentration by using the pulse photometer.
  • A pulse photometer is an apparatus which measures the blood light absorber concentration of the subject. Specifically, the living tissue of the subject is irradiated with light beams at a plurality of wavelengths which have different ratios of the blood light absorbances depending on the blood light absorber concentration. The intensities of the light beams at the wavelengths transmitted through or reflected from the living tissue are detected. The intensities at the wavelengths are changed in accordance with the pulsation of the blood in the subject. Therefore, temporal changes of the intensities at the wavelengths due to the pulsation are acquired in the form of a pulse wave signal. The amplitudes of pulse wave signals with respect to waveforms correspond to light attenuation variations with respect to the waveforms, respectively. The blood light absorber concentration calculated based on a ratio of light attenuation variations with respect to waveforms (for example, see Japanese Patent No. 4,196,209).
  • As an example of the blood light absorber concentration, known is the arterial oxygen saturation (hereinafter, referred to as the SaO2) which is used as an index of oxygenation of blood. In order to obtain the value of the SaO2, an invasive measurement must be performed. Therefore, the transcutaneous arterial oxygen saturation (hereinafter, referred to as the SpO2) which can be non-invasively calculated is widely used as the index. The SpO2 is measured by a pulse oximeter which is an example of a pulse photometer.
  • Ideally, the value of the calculated SpO2 is equal to that of the actual SaO2. However, it is known that the values are different from each other under certain conditions. In the case where the pulse wave signal has a low amplitude, particularly, the value of the SpO2 tends to be calculated to be higher than that of the actual SaO2. In this case, a situation where, even when the value of the SpO2 indicates the normal condition of the subject, the subject actually suffers hypoxemia is possibly caused.
  • SUMMARY
  • The presently disclosed subject matter may provide an apparatus and a method to improve the accuracy of a blood light absorber concentration which is non-invasively calculated.
  • There may be provided a pulse photometer comprising: a first variation acquirer which is configured to acquire a first variation corresponding to a light attenuation variation of a first light beam due to pulsation of blood in a subject, based on a first intensity signal corresponding to an intensity of the first light beam that is transmitted through or reflected from a body of the subject, and that has a first wavelength; a second variation acquirer which is configured to acquire a second variation corresponding to a light attenuation variation of a second light beam due to the pulsation of the blood in the subject, based on a second intensity signal corresponding to an intensity of the second light beam that is transmitted through or reflected from the body of the subject, and that has a second wavelength; and a concentration calculator which is configured to calculate a blood light absorber concentration, based on the first variation and the second variation, the second variation containing a first offset which is based on an inverse of the light attenuation variation of the first light beam.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a block diagram illustrating the functional configuration of a pulse oximeter of a first embodiment.
  • FIGS. 2(A) and 2(B) are views illustrating the operation of the pulse oximeter of FIG. 1.
  • FIG. 3 is a block diagram illustrating the functional configuration of a pulse oximeter of a second embodiment.
  • FIGS. 4(A) and 4(B) are views illustrating the operation of the pulse oximeter of FIG. 3.
  • DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
  • Hereinafter, embodiments will be described in detail with reference to the accompanying drawings. FIG. 1 is a block diagram illustrating the functional configuration of a pulse oximeter 1 (an example of the pulse photometer) of a first embodiment. The pulse oximeter 1 is an apparatus which measures the SpO2 of a subject 2. The SpO2 indicates a ratio (an example of the blood light absorber concentration) of oxyhemoglobin (an example of the blood light absorber) to the amount of hemoglobin capable of carrying oxygen.
  • The pulse oximeter 1 can include a first light emitter 11. The first light emitter 11 is configured so as to emit a first light beam having a first wavelength λ1. Examples of the first wavelength λ1 are 880 nm and 940 nm (examples of the infrared light beam). For example, the first light emitter 11 is a semiconductor light emitting device which can emit the first light beam. Examples of the semiconductor light emitting device are a light emitting diode (LED), a laser diode, and an organic electroluminescence.
  • The pulse oximeter 1 can include a second light emitter 12. The second light emitter 12 is configured so as to emit a second light beam having a second wavelength λ2. Examples of the second wavelength λ2 are 630 nm and 660 nm (examples of the red light beam). For example, the second light emitter 12 is a semiconductor light emitting device which can emit the second light beam. Examples of the semiconductor light emitting device are a light emitting diode (LED), a laser diode, and an organic electroluminescence.
  • The pulse oximeter 1 can include a light detector 20. The light detector 20 is configured so as to output a first intensity signal I1 in accordance with the intensity of the first light beam transmitted through or reflected from the body of the subject 2. Moreover, the light detector 20 is configured so as to output a second intensity signal I2 in accordance with the intensity of the second light beam transmitted through or reflected from the body of the subject 2. For example, the light detector 20 is an optical sensor having a sensitivity to, for example, the first wavelength λ1 and the second wavelength λ2. Examples of the optical sensor are a photodiode, a phototransistor, and a photoresistor.
  • The pulse oximeter 1 can include a first variation acquirer 31. The first variation acquirer 31 is configured so as to acquire a light attenuation variation ΔA1 of the first light beam due to the blood pulsation of the subject 2 based on a temporal change of the first intensity signal I1 output from the light detector 20. The light attenuation variation ΔA1 of the first light beam is expressed by the following expression:

  • ΔA1=ln [I1/(I1−ΔI1)]≈ΔI1/I1  (1)
  • where ΔI1 indicates the variation of the first intensity signal I1 due to the blood pulsation of the subject 2.
  • The pulse oximeter 1 can include a second variation acquirer 32. The second variation acquirer 32 is configured so as to acquire a light attenuation variation ΔA2 of the second light beam due to the blood pulsation of the subject 2 based on a temporal change of the second intensity signal I2 output from the light detector 20. The light attenuation variation ΔA2 of the second light beam is expressed by the following expression:

  • ΔA2=ln [I2/(I2−ΔI2)]≈ΔI2/I2  (2)
  • where ΔI2 indicates the variation of the second intensity signal I2 due to the blood pulsation of the subject 2.
  • As described above, in the case where the pulse wave signal has a low amplitude, particularly, the value of the SpO2 acquired by the pulse oximeter tends to be higher than that of the arterial oxygen saturation (hereinafter, referred to as the SaO2) which is invasively acquired. The inventors have focused on the light attenuation variation ΔA1 of the first light beam corresponding to the amplitude of the pulse wave signal, and investigated a relationship between the variation and the difference between the value of the SpO2 and that of the SaO2.
  • FIG. 2(A) illustrates results of the investigation. The abscissa represents the inverse of the light attenuation variation ΔA1 of the first light beam. Therefore, the figure illustrates a situation where the larger the value, the lower the amplitude of the pulse wave signal. The ordinate represents the difference between the value of the SpO2 and that of the SaO2. Namely, the ordinate indicates the bias contained in the value of the acquired SpO2. The inventors have found that the inverse of the light attenuation variation ΔA1 of the first light beam and the bias contained in the value of the acquired SpO2 are in proportional relationships. That is, the following expression is obtained:

  • SpO2−SaO2=−k1/ΔA1  (3)
  • where k1 is a proportional constant.
  • The value of the SaO2 can be regarded as a reference value for the SpO2 acquired by the pulse oximeter. From Expression (3), the reference value can be expressed by the following expression:

  • SaO2=SpO2+(k1/ΔA1)  (4)
  • Namely, the right side of Expression (3) can be regarded as an offset necessary for obtaining the accurate value of the SpO2. According to Expression (4), it is seen that the reference value is obtained by adding the offset to the value of the SpO2 acquired by the pulse oximeter.
  • On the other hand, the SpO2 is a function of a light attenuation variation ratio Φ21 (=ΔA2/ΔA1) which is a ratio of the light attenuation variation ΔA2 of the second light beam to the light attenuation variation ΔA1 of the first light beam. From Expression (4), therefore, the following expression is obtained:
  • SaO 2 Φ 21 + ( k 1 / Δ A 1 ) ( Δ A 2 / Δ A 1 ) + ( k 1 / Δ A 1 ) ( Δ A 2 + k 1 ) / Δ A 1 ( 5 )
  • Namely, it is seen that the value of the SpO2 acquired by the pulse oximeter can approach that of the SaO2 by adding an offset corresponding to the proportional constant k1 which is obtained from the relationships shown in FIG. 2(A), to the light attenuation variation ΔA2 of the second light beam.
  • The first variation acquirer 31 is configured so as to acquire a first variation Δ1 corresponding to the light attenuation variation ΔA1 of the first light beam. The first variation Δ1 is substantially identical to the light attenuation variation ΔA1 of the first light beam.
  • The second variation acquirer 32 is configured so as to acquire a second variation Δ2 corresponding to the light attenuation variation ΔA2 of the second light beam. The second variation Δ2 is set as the following expression based on the above-described finding:

  • Δ2=ΔA2+k1  (6)
  • In the expression, k1 is regarded as the first offset based on the inverse of the light attenuation variation ΔA1 of the first light beam. That is, the second variation Δ2 contains the first offset k1.
  • The pulse oximeter 1 can include a concentration calculator 40. The concentration calculator 40 is configured so as to calculate the SpO2 of the subject 2 based on the first variation Δ1 acquired by the first variation acquirer 31, and the second variation Δ2 acquired by the second variation acquirer 32. Specifically, the concentration calculator is configured so as to calculate the SpO2 based on Expression (5).
  • Similarly with FIG. 2(A), FIG. 2(B) illustrates the difference between the value of the SpO2 which is calculated by the pulse oximeter 1 including the concentration calculator 40, and that of the SaO2. It is seen that, although the difference between the values is not eliminated, the bias in a region where the pulse wave amplitude is low (region where the inverse of the light attenuation variation ΔA1 of the first light beam is large) is reduced as compared with the example in which the first offset k1 is not used. According to the configuration, therefore, it is possible to improve the accuracy of the SpO2 which is non-invasively calculated.
  • The value of the first offset k1 may be adequately determined. In the embodiment, the value of the first offset k1 is previously statistically determined based on a plurality of difference values between the SpO2 and the SaO2 which are acquired from a plurality of subjects. Specifically, a statistical process such as the least squares method is applied to a plurality of measurement results such as shown in FIG. 2(A), and the first offset k1 by which the difference between the SpO2 and the SaO2 can be reduced is determined.
  • According to the configuration, the second variation acquirer 32 operates based on the first offset k1 which is a constant that is statistically determined. Therefore, the reliability of the first offset k1 can be improved, and furthermore the processing load of the second variation acquirer 32 can be reduced. Consequently, the accuracy of the SpO2 which is non-invasively calculated can be easily improved.
  • In the embodiment, an infrared light beam is used as the first light beam, and a red light beam is used as the second light beam. Alternatively, a red light beam may be used as the first light beam, and an infrared light beam may be used as the second light beam.
  • The embodiment is configured so that the common light detector 20 detects the first light beam emitted from the first light emitter 11, and the second light beam emitted from the second light emitter 12. Alternatively, a configuration may be employed where a light detector for detecting the first light beam, and that for detecting the second light beam are arranged independently from each other.
  • FIG. 3 is a diagram illustrating the functional configuration of a pulse oximeter 1A of a second embodiment. Portions which are identical or substantially identical with those of the pulse oximeter 1 of the first embodiment are denoted by the same reference numerals, and duplicated descriptions are omitted.
  • The pulse oximeter 1A can include a third light emitter 13. The third light emitter 13 is configured so as to emit a third light beam having a third wavelength λ3. Examples of the third wavelength λ3 are 700 nm (an example of the red light beam) 730 nm (an example of the red light beam), and 805 nm (an example of the infrared light beam). For example, the third light emitter 13 is a semiconductor light emitting device which can emit the third light beam. Examples of the semiconductor light emitting device are a light emitting diode (LED), a laser diode, and an organic electroluminescence.
  • The light detector 20 is configured so as to output a third intensity signal I3 in accordance with the intensity of the third light beam transmitted through or reflected from the body of the subject 2.
  • The pulse oximeter 1A can include a third variation acquirer 33. The third variation acquirer 33 is configured so as to acquire a light attenuation variation ΔA3 of the third light beam due to the blood pulsation of the subject 2 based on a temporal change of the third intensity signal I3 output from the light detector 20. The light attenuation variation ΔA3 of the third light beam is expressed by the following expression:

  • ΔA3=ln [I3/(I3−ΔI3)]≈ΔI3/I3  (7)
  • where ΔI3 indicates the variation of the third intensity signal I3 due to the blood pulsation of the subject 2.
  • FIG. 4(A) illustrates relationships of the inverse of the light attenuation variation ΔA1 of the first light beam in the case where the SpO2 is measured by using the three wavelengths, and the difference between the value of the SpO2 and that of the SaO2. The abscissa corresponds to the former, and the ordinate corresponds to the latter. The inventors have found that, also in the case where the three wavelengths are used, the inverse of the light attenuation variation ΔA1 of the first light beam and the bias contained in the value of the acquired SpO2 are in proportional relationships.
  • The SpO2 is also a function of a light attenuation variation ratio Φ31 (=ΔA3/ΔA1) which is a ratio of the light attenuation variation ΔA3 of the third light beam to the light attenuation variation ΔA1 of the first light beam. From Expression (4), therefore, the following expression is obtained:
  • SaO 2 Φ 21 + ( k 1 / Δ A 1 ) , Φ 31 + ( k 2 / Δ A 1 ) ( Δ A 2 / Δ A 1 ) + ( k 1 / Δ A 1 ) , ( Δ A 3 / Δ A 1 ) + ( k 2 / Δ A 1 ) ( Δ A 2 + k 1 ) / Δ A 1 , ( Δ A 3 + k 2 ) / Δ A 1 ( 8 )
  • Namely, it is seen that the value of the SpO2 acquired by the pulse oximeter can approach that of the SaO2 by adding the first offset k1 which is obtained from the relationships shown in FIG. 4(A), to the light attenuation variation ΔA2 of the second light beam, and further adding a second offset k2 to the light attenuation variation ΔA3 of the third light beam.
  • The third variation acquirer 33 is configured so as to acquire a third variation Δ3 corresponding to the light attenuation variation ΔA3 of the third light beam. The third variation Δ3 is set as the following expression based on the above-described finding:

  • Δ3=ΔA3+k2  (9)
  • In the expression, k2 is regarded as the second offset based on the inverse of the light attenuation variation ΔA1 of the first light beam. That is, the third variation Δ3 contains the second offset k2.
  • The pulse oximeter 1A can include a concentration calculator 40A. The concentration calculator 40A is configured so as to calculate the SpO2 of the subject 2 based on the first variationΔ1 acquired by the first variation acquirer 31, the second variationΔ2 acquired by the second variation acquirer 32, and the third variation Δ3 acquired by the third variation acquirer 33. Specifically, the concentration calculator is configured so as to perform the process described below.
  • The light attenuation variations ΔA1, ΔA2, and ΔA3 of the first, second, and third light beams are expressed by the following expressions:

  • ΔA1=ΔAb1+ΔAt1=Eb1HbΔDb+ΣtDt  (10)

  • ΔA2=ΔAb2+ΔAt2=Eb2HbΔDb+ΣtDt  (11)

  • ΔA3=ΔAb3+ΔAt3=Eb3HbΔDb+ΣtDt  (12)
  • where E is the extinction coefficient (dl g−1 cm−1), Hb is the hemoglobin concentration of blood (g dl−1), Σ indicates the light attenuation rate (cm−1), and ΔD indicates the thickness change (cm) due to the blood pulsation. The suffix “b” means blood, the suffix “t” means the tissue except blood, the suffix “1” means the first light beam, the suffix “2” means the second light beam, and the suffix “3” means the third light beam.
  • Expressions (10) to (12) can be deformed in the following manner:
  • Δ A 1 = Eb 1 hb Δ Db + Σ t 1 Δ Dt = [ Eb 1 + ( Σ t 1 Δ Dt ) / ( Hb Δ Db ) ] ( Hb Δ Db ) = ( Eb 1 + Ex 1 ) ( Hb Δ Db ) ( 13 ) Δ A 2 = Eb 2 Hb Δ Db + Σ t 2 Δ D t = [ Eb 2 + ( Σ t 2 Δ Dt ) / ( Hb Δ Db ) ] ( Hb Δ Db ) = ( Eb 2 + Ex 2 ) ( Hb Δ Db ) ( 14 ) Δ A 3 = Eb 3 Hb Δ Db + Σ t 3 Δ D t = [ Eb 3 + ( Σ t 3 Δ Dt ) / ( Hb Δ Db ) ] ( Hb Δ Db ) ( Eb 3 + Ex 3 ) ( Hb Δ Db ) ( 15 )
  • where Ex indicates a variable which is replaced with [(ΣtΔDt)/(HbΔDb)], the suffix “1” means the first light beam, the suffix “2” means the second light beam, and the suffix “3” means the third light beam.
  • Expressions (13) to (15) can be deformed in the following manner:

  • Eb1+Ex1−ΔA1/(HbΔDb)=0  (16)

  • Eb2+Ex2−ΔA2/(HbΔDb)=0  (17)

  • Eb3+Ex3−ΔA3/(HbΔDb)=0  (18)
  • With respect to Expressions (16) to (18), the blood extinction coefficient Eb2 of the second light beam, and the blood extinction coefficient Eb3 of the third light beam can be approximated by the blood extinction coefficient Eb1 of the first light beam in the following manner:

  • Eb2=a2Eb1+b2  (19)

  • Eb3=a3Eb1+b3  (20)
  • where a and b are constants, the suffix “1” means the first light beam, the suffix “2” means the second light beam, and the suffix “3” means the third light beam.
  • With respect to Expressions (16) to (18), Ex2 of the second light beam and Ex3 of the third light beam can be approximated to by Ex1 of the first light beam in the following manner:

  • Ex2=α2Ex1+β2  (21)

  • Ex3=α3Ex1+β3  (22)
  • where α and β are constants, the suffix “1” means the first light beam, the suffix “2” means the second light beam, and the suffix “3” means the third light beam.
  • Expressions (16) to (18) are rewritten by using Expressions (19) to (22), and the following expressions are obtained:

  • Eb1+Ex1−ΔA1/(HbΔDb)=0  (23)

  • (a2Eb1+b2)+(α2Ex1+β2)−ΔA2/(HbΔDb)=0 a2Eb1+α2Ex1−ΔA2/(HbΔDb)=−b2−β2  (24)

  • (a3Eb1+b3)+(α3Ex1+β3)−ΔA3/(HbΔDb)=0 a3Eb1+α3Ex1−ΔA3/(HbΔDb)=−b3−β3  (25)
  • When the following matrix expression is calculated, therefore, the blood extinction coefficient Eb1 of the first light beam is obtained:
  • ( 1 1 - Δ A 1 a 2 α 2 - Δ A 2 a 3 α 3 - Δ A 3 ) ( Eb 1 Ex 1 1 Hb Δ b ) = ( 0 - b 2 - β 2 - b3 - β 3 ) ( 26 )
  • When the SpO2 which is expressed in a percentage notification is expressed as S which is expressed in a decimal notification, the blood extinction coefficient Eb1 is expressed by the following expression:

  • Eb1=Eo1S+Er1(1−S)  (27)
  • where Eo is the extinction coefficient of oxyhemoglobin, Er is the extinction coefficient of deoxyhemoglobin, and the suffix “1” means the first light beam.
  • Here, it is seen that the value of SpO2 acquired by the pulse oximeter can approach that of the SaO2 by adding the first offset k1 to the light attenuation variation ΔA2 of the second light beam, and adding the second offset k2 to the light attenuation variation ΔA3 of the third light beam.
  • ( 1 1 - Δ A 1 a 2 α 2 - ( Δ A 2 + k 1 ) a 3 α 3 - ( Δ A 3 + k 2 ) ) ( Eb 1 Ex 1 1 Hb Δ b ) = ( 0 - b 2 - β 2 - b3 - β 3 ) ( 28 )
  • Expression (28) is rewritten by using Expressions (6) and (9), and the following expression is obtained:
  • ( 1 1 - Δ 1 a 2 α 2 - Δ 2 a 3 α 3 - Δ3 ) ( Eb 1 Ex 1 1 Hb Δ b ) = ( 0 - b 2 - β 2 - b3 - β 3 ) ( 29 )
  • Therefore, it is seen that the concentration calculator 40A is configured so as to calculate the SpO2 based on the first variation Δ1 acquired by the first variation acquirer 31, the second variationΔ2 acquired by the second variation acquirer 32, and the third variation Δ3 acquired by the third variation acquirer 33.
  • Similarly with FIG. 4(A), FIG. 4(B) illustrates the difference between the value of the SpO2 which is calculated by the pulse oximeter 1A including the concentration calculator 40A, and that of the SaO2. It is seen that the bias in a region where the pulse wave amplitude is low (region where the inverse of the light attenuation variation ΔA1 of the first light beam is large) is greatly reduced as compared with the example in which the first offset k1 and the second offset k2 are not used.
  • According to the configuration, therefore, it is possible to largely improve the accuracy of the SpO2 which is non-invasively calculated.
  • The values of the first offset k1 and the second offset k2 may be adequately determined. In the embodiment, the values of the first offset k1 and the second offset k2 are previously statistically determined based on a plurality of difference values between the SpO2 and the SaO2 which are acquired from a plurality of subjects. Specifically, a statistical process such as the least squares method is applied to a plurality of measurement results such as shown in FIG. 4(A), and the first offset k1 and second offset k2 by which the difference between the SpO2 and the SaO2 can be reduced are determined.
  • According to the configuration, the second variation acquirer 32 operates based on the first offset k1 which is a constant that is statistically determined, and the third variation acquirer 33 operates based on the second offset k2 which is a constant that is statistically determined. Therefore, the reliabilities of the first offset k1 and the second offset k2 can be improved, and furthermore the processing loads of the second variation acquirer 32 and the third variation acquirer 33 can be reduced. Consequently, the accuracy of the SpO2 which is non-invasively calculated can be easily and remarkably improved.
  • In the embodiment, an infrared light beam is used as the first light beam, and a red light beam is used as the second and third light beams. Alternatively, a red light beam may be used as the first light beam, a red light beam may be used as one of the second and third light beams, and an infrared light beam may be used as the other one of the second and third light beams. Alternatively, an infrared light beam may be used as two of the first, second, and third light beams, and a red light beam may be used as the remaining one of the light beams.
  • The embodiment is configured so that the common light detector 20 detects the first light beam emitted from the first light emitter 11, the second light beam emitted from the second light emitter 12, and the third light beam emitted from the third light emitter 13. Alternatively, a configuration may be employed where at least one of the light detector for detecting the first light beam, that for detecting the second light beam, and that for detecting the third light beam is independently arranged.
  • The red light beam and the infrared light beam are a combination in which ratios of the blood light absorbances are varied depending on the oxygen saturation, and therefore particularly the accuracy of the calculation of the SpO2 can be improved.
  • The above-described embodiments are mere examples for facilitating understanding of the invention. The configurations of the embodiments may be adequately changed or improved without departing from the spirit of the invention. It is obvious that equivalents are included within the technical scope of the invention.
  • In the above-described embodiments, a pulse oximeter for calculating the SpO2 has been exemplified. However, the presently disclosed subject matter can be applied also to other kinds of pulse photometers which measure the concentration of another blood light absorber. Examples of another blood light abosrober are carboxyhemoglobin, methhemoglobin, and a dye injected into blood vessels. In this case, the wavelengths of the light beams are selected so that combinations can be produced in which ratios of the blood light absorbances are substantially different from each other depending on the target blood light absorber concentration.
  • A configuration may be employed where four or more light beams at four or more wavelengths are used for identifying the blood light absorber concentration. For example, four wavelengths λ1, λ2, λ3, and λ4 may be selected as follows:
  • λ1=630 nm, λ2=660 nm, λ3=700 nm, λ4=880 nm; or
  • λ1=660 nm, λ2=700 nm, λ3=880 nm, λ4=940 nm.
  • In the above-described embodiments, the functions of the first variation acquirer 31, the second variation acquirer 32, the third variation acquirer 33, and the concentration calculator 40 (40A) are realized from software executed by a cooperation of a processor and memory which are communicable connected to each other. Examples of the processor are a CPU and an MPU. Examples of the memory are a RAM and a ROM. However, at least one of the functions of the first variation acquirer 31, the second variation acquirer 32, the third variation acquirer 33, and the concentration calculator 40 (40A) may be realized by hardware such as circuit devices, or a combination of hardware and software.

Claims (8)

What is claimed is:
1. A pulse photometer comprising:
a first light emitter which is configured to emit a first light beam having a first wavelength;
a second light emitter which is configured to emit a second light beam having a second wavelength;
a light detector which is configured to output a first intensity signal in accordance with an intensity of the first light beam that is transmitted through or reflected from a body of a subject, and a second intensity signal in accordance with an intensity of the second light beam that is transmitted through or reflected from the body of the subject;
a first variation acquirer which is configured to acquire a first variation corresponding to a light attenuation variation of the first light beam due to the pulsation of the blood in the subject, based on the first intensity signal;
a second variation acquirer which is configured to acquire a second variation corresponding to a light attenuation variation of the second light beam due to the pulsation of the blood in the subject, based on the second intensity signal; and
a concentration calculator which is configured to calculate a blood light absorber concentration, based on the first variation and the second variation,
the second variation containing a first offset which is based on an inverse of the light attenuation variation of the first light beam.
2. The pulse photometer according to claim 1, wherein
the first offset which is a constant that is previously statistically determined based on a plurality of blood light absorber concentrations acquired from a plurality of subjects.
3. The pulse photometer according to claim 1, wherein
one of the first light beam and the second light beam is a red light beam, and
the other of the first light beam and the second light beam is an infrared light beam.
4. The pulse photometer according to claim 1, further comprising:
a third light emitter; and
a third variation acquirer, wherein
the third light emitter is configured to emit a third light beam having a third wavelength,
the light detector is configured to output a third intensity signal in accordance with an intensity of the third light beam that is transmitted through or reflected from the body of the subject,
the third variation acquirer is configured to acquire a third variation corresponding to a light attenuation variation of the third light beam due to the pulsation of the blood in the subject, based on the third intensity signal,
the concentration calculator is configured to calculate the blood light absorber concentration, based on the first variation, the second variation, and the third variation, and
the third variation contains a second offset which is based on an inverse of the light attenuation variation of the first light beam.
5. The pulse photometer according to claim 4, wherein
the second offset is a constant that is previously statistically determined based on a plurality of blood light absorber concentrations acquired from a plurality of subjects.
6. The pulse photometer according to claim 4, wherein
the first wavelength, the second wavelength, and the third wavelength are selected from 630 nm, 660 nm, 700 nm, 730 nm, 805 nm, 880 nm, and 940 nm.
7. A pulse photometer comprising:
a first variation acquirer which is configured to acquire a first variation corresponding to a light attenuation variation of a first light beam due to pulsation of blood in a subject, based on a first intensity signal corresponding to an intensity of the first light beam that is transmitted through or reflected from a body of the subject, and that has a first wavelength;
a second variation acquirer which is configured to acquire a second variation corresponding to a light attenuation variation of a second light beam due to the pulsation of the blood in the subject, based on a second intensity signal corresponding to an intensity of the second light beam that is transmitted through or reflected from the body of the subject, and that has a second wavelength; and
a concentration calculator which is configured to calculate a blood light absorber concentration, based on the first variation and the second variation,
the second variation containing a first offset which is based on an inverse of the light attenuation variation of the first light beam.
8. A method for calculating a blood light absorber concentration, the method comprising:
causing a pulse photometer to acquire a first variation corresponding to a light attenuation variation of a first light beam due to pulsation of blood in a subject, based on a first intensity signal corresponding to an intensity of the first light beam that is transmitted through or reflected from a body of the subject, and that has a first wavelength;
causing the pulse photometer to acquire a second variation corresponding to a light attenuation variation of a second light beam due to the pulsation of the blood in the subject, based on a second intensity signal corresponding to an intensity of the second light beam that is transmitted through or reflected from the body of the subject, and that has a second wavelength; and
causing the pulse photometer to calculate the blood light to absorber concentration, based on the first variation and the second variation,
the second variation containing a first offset which is based on an inverse of the light attenuation variation of the first light beam.
US15/059,564 2015-03-04 2016-03-03 Pulse photometer and method for calculating concentration of light absorber in blood Active 2037-09-03 US10524704B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2015-042600 2015-03-04
JP2015042600 2015-03-04
JP2016008856A JP6703841B2 (en) 2015-03-04 2016-01-20 Pulse photometer and method for calculating blood light-absorbing substance concentration
JP2016-008856 2016-01-20

Publications (2)

Publication Number Publication Date
US20160256089A1 true US20160256089A1 (en) 2016-09-08
US10524704B2 US10524704B2 (en) 2020-01-07

Family

ID=55524142

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/059,564 Active 2037-09-03 US10524704B2 (en) 2015-03-04 2016-03-03 Pulse photometer and method for calculating concentration of light absorber in blood

Country Status (2)

Country Link
US (1) US10524704B2 (en)
EP (1) EP3064137B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3912549A3 (en) * 2020-05-20 2021-12-01 Nihon Kohden Corporation Pulse photometer, pulse photometry system and computer program

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221463A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc System and method for venous pulsation detection using near infrared wavelengths
US20090318787A1 (en) * 2008-06-19 2009-12-24 Nihon Kohden Corporation Pulse oximetry and pulse oximeter
US20100324384A1 (en) * 2009-06-17 2010-12-23 Jim Moon Body-worn pulse oximeter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5782756A (en) 1996-09-19 1998-07-21 Nellcor Puritan Bennett Incorporated Method and apparatus for in vivo blood constituent analysis
JP3627214B2 (en) 1999-09-13 2005-03-09 日本光電工業株式会社 Blood absorption substance measuring device
JP4284674B2 (en) * 2003-01-31 2009-06-24 日本光電工業株式会社 Absorbent concentration measuring device in blood
JP4196209B2 (en) 2003-06-30 2008-12-17 日本光電工業株式会社 Signal processing method and pulse photometer using the same
US7025728B2 (en) 2003-06-30 2006-04-11 Nihon Kohden Corporation Method for reducing noise, and pulse photometer using the method
WO2008154643A1 (en) * 2007-06-12 2008-12-18 Triage Wireless, Inc. Vital sign monitor for measuring blood pressure using optical, electrical, and pressure waveforms
JP5353790B2 (en) * 2010-03-30 2013-11-27 コニカミノルタ株式会社 Biological information measuring apparatus and method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221463A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc System and method for venous pulsation detection using near infrared wavelengths
US20090318787A1 (en) * 2008-06-19 2009-12-24 Nihon Kohden Corporation Pulse oximetry and pulse oximeter
US20100324384A1 (en) * 2009-06-17 2010-12-23 Jim Moon Body-worn pulse oximeter

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Mendelson, "Pulse Oximetry", Wiley Encyclopedia of Biomedical Engineering, 2006, pp 1-18 *
Nogawa et al. 'New Hybrid Reflectance Optical Pulse Oximetry Sensor for Lower Oxygen Saturation Measurement and for Broader Clinical Application, Proc. SPIE 2976, 16 June 1997 *
Suzaki et al., 'Noninvasive measurement of total hemoglobin and hemoglobin derivatives using multiwavelength pulse spectrophotometry', IEEE, 30 Aug 2006 *
Takatani et al., "Experimental and Clinical Evaluation of a Noninvasive Reflectance Pulse Oximeter Sensor', J. Clinical Monitoring, Vol. 8, No. 4, Oct 1992 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3912549A3 (en) * 2020-05-20 2021-12-01 Nihon Kohden Corporation Pulse photometer, pulse photometry system and computer program

Also Published As

Publication number Publication date
EP3064137A1 (en) 2016-09-07
EP3064137B1 (en) 2020-12-23
US10524704B2 (en) 2020-01-07

Similar Documents

Publication Publication Date Title
US11647923B2 (en) Tissue profile wellness monitor
US10702196B2 (en) Pulse photometer
US8694067B2 (en) Sensor, apparatus and method for non-invasively monitoring blood characteristics of a subject
US20160066863A1 (en) METHOD AND APPARATUS FOR DETERMINING SpO2 OF A SUBJECT FROM AN OPTICAL MEASUREMENT
US10039500B2 (en) System and method for blood typing using PPG technology
KR20020081763A (en) Method and apparatus for noninvasively measuring hemoglobin concentration and oxygen saturation
US20210177359A1 (en) System and method for determining blood disorders for a blood type using ppg technology
US20230218208A1 (en) Medical photometer and medical photometry system
US20200405205A1 (en) Method for measuring blood oxygen saturation
US10561375B2 (en) Pulse photometer and method for evaluating reliability of calculated value of blood light absorber concentration
US10524704B2 (en) Pulse photometer and method for calculating concentration of light absorber in blood
US9597025B2 (en) Biological signal measuring system and biological signal measuring apparatus
US20180317825A1 (en) Device and method for measuring the concentration of a chemical compound in blood
JP6703841B2 (en) Pulse photometer and method for calculating blood light-absorbing substance concentration
JP6741485B2 (en) Pulse photometer and reliability evaluation method for calculated values of blood light-absorbing substance concentration
US10342465B2 (en) Medical photometer and medical photometer control method
US10722153B2 (en) Medical photometer and medical photometer control method
US20210361202A1 (en) Pulse photometer, pulse photometry system and computer-readable medium
US20240016417A1 (en) Method and system for detection of glucose and other compounds using swirr
JP2019150104A (en) Pulse oximeter and blood characteristic measuring apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: NIHON KOHDEN CORPORATION, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:UEDA, YOSHINORI;UKAWA, TEIJI;ITO, KAZUMASA;AND OTHERS;REEL/FRAME:038226/0559

Effective date: 20160309

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4